Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit - manually
(-)Asym./Biol. Unit
collapse expand < >
Image Asym./Biol. Unit - manually
Asym./Biol. Unit - manually  (Jmol Viewer)
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)

(-) Description

Title :  SEC14 HOMOLOGY MODULE OF NEUROFIBROMIN IN COMPLEX WITH PHOSPHATITYLETHANOLAMINE
 
Authors :  I. D'Angelo, S. Welti, K. Scheffzek
Date :  18 Nov 06  (Deposition) - 02 Oct 07  (Release) - 24 Feb 09  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.50
Chains :  Asym./Biol. Unit :  A,B
Keywords :  Sec14, Ph Superfold, Pe, Cral-Trio Domain, Signaling Protein (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  S. Welti, S. Fraterman, I. D'Angelo, M. Wilm, K. Scheffzek
The Sec14 Homology Module Of Neurofibromin Binds Cellular Glycerophospholipids: Mass Spectrometry And Structure Of A Lipid Complex
J. Mol. Biol. V. 366 551 2007
PubMed-ID: 17187824  |  Reference-DOI: 10.1016/J.JMB.2006.11.055
(for further references see the PDB file header)

(-) Compounds

Molecule 1 - NEUROFIBROMIN
    ChainsA, B
    EngineeredYES
    Expression SystemESCHERICHIA COLI BL21(DE3)
    Expression System PlasmidPET
    Expression System StrainBL21(DE3)
    Expression System Taxid469008
    Expression System Vector TypePLASMID
    FragmentNF1
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymNEUROFIBROMIN SEC-PH SEGMENT, NEUROFIBROMATOSIS- RELATED PROTEIN NF-1

 Structural Features

(-) Chains, Units

  12
Asymmetric/Biological Unit AB

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (2, 4)

Asymmetric/Biological Unit (2, 4)
No.NameCountTypeFull Name
1PEV2Ligand/Ion(1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE
2POP2Ligand/IonPYROPHOSPHATE 2-

(-) Sites  (0, 0)

(no "Site" information available for 2E2X)

(-) SS Bonds  (0, 0)

(no "SS Bond" information available for 2E2X)

(-) Cis Peptide Bonds  (0, 0)

(no "Cis Peptide Bond" information available for 2E2X)

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (3, 6)

Asymmetric/Biological Unit (3, 6)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_021759I1605VNF1_HUMANDisease (NF1)199474766A/BI1584V
2UniProtVAR_002660R1611WNF1_HUMANDisease (NF1)  ---A/BR1590W
3UniProtVAR_021760A1785SNF1_HUMANDisease (NF1)199474782A/BA1764S

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (0, 0)

(no "PROSITE Motif" information available for 2E2X)

(-) Exons   (3, 6)

Asymmetric/Biological Unit (3, 6)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENST000003582731aENSE00002148166chr17:29421945-29422387443NF1_HUMAN1-20200--
1.2aENST000003582732aENSE00002094730chr17:29483001-29483144144NF1_HUMAN21-68480--
1.3aENST000003582733aENSE00002094214chr17:29486028-2948611184NF1_HUMAN69-96280--
1.4ENST000003582734ENSE00002118260chr17:29490204-29490394191NF1_HUMAN97-160640--
1.5ENST000003582735ENSE00002099784chr17:29496909-29497015107NF1_HUMAN160-196370--
1.6ENST000003582736ENSE00002120628chr17:29508440-2950850768NF1_HUMAN196-218230--
1.7ENST000003582737ENSE00002092460chr17:29508728-2950880376NF1_HUMAN219-244260--
1.8aENST000003582738aENSE00002125254chr17:29509526-29509683158NF1_HUMAN244-296530--
1.9aENST000003582739aENSE00002115113chr17:29527440-29527613174NF1_HUMAN297-354580--
1.10ENST0000035827310ENSE00002099597chr17:29528055-29528177123NF1_HUMAN355-395410--
1.11ENST0000035827311ENSE00002134856chr17:29528429-2952850375NF1_HUMAN396-420250--
1.12ENST0000035827312ENSE00002094687chr17:29533258-29533389132NF1_HUMAN421-464440--
1.13ENST0000035827313ENSE00002128833chr17:29541469-29541603135NF1_HUMAN465-509450--
1.14aENST0000035827314aENSE00002120232chr17:29546023-29546136114NF1_HUMAN510-547380--
1.15aENST0000035827315aENSE00001718967chr17:29548868-2954894780NF1_HUMAN548-574270--
1.16ENST0000035827316ENSE00001682385chr17:29550462-29550585124NF1_HUMAN574-615420--
1.17bENST0000035827317bENSE00001674165chr17:29552113-29552268156NF1_HUMAN616-667520--
1.18ENST0000035827318ENSE00001656817chr17:29553453-29553702250NF1_HUMAN668-751840--
1.19ENST0000035827319ENSE00001637281chr17:29554236-2955430974NF1_HUMAN751-775250--
1.20ENST0000035827320ENSE00001777991chr17:29554541-2955462484NF1_HUMAN776-803280--
1.21aENST0000035827321aENSE00001672348chr17:29556043-29556483441NF1_HUMAN804-9501470--
1.21cENST0000035827321cENSE00001753969chr17:29556853-29556992140NF1_HUMAN951-997470--
1.22ENST0000035827322ENSE00001681705chr17:29557278-29557400123NF1_HUMAN997-1038420--
1.23ENST0000035827323ENSE00001680511chr17:29557860-2955794384NF1_HUMAN1038-1066290--
1.24ENST0000035827324ENSE00001787054chr17:29559091-29559207117NF1_HUMAN1066-1105400--
1.25ENST0000035827325ENSE00001739464chr17:29559718-29559899182NF1_HUMAN1105-1166620--
1.26aENST0000035827326aENSE00001685335chr17:29560020-29560231212NF1_HUMAN1166-1236710--
1.27ENST0000035827327ENSE00001597402chr17:29562629-29562790162NF1_HUMAN1237-1290540--
1.28ENST0000035827328ENSE00001736567chr17:29562936-29563039104NF1_HUMAN1291-1325350--
1.29ENST0000035827329ENSE00001614962chr17:29576002-29576137136NF1_HUMAN1325-1370460--
1.31ENST0000035827331ENSE00001105172chr17:29579956-2958001863NF1_HUMAN1371-1391210--
1.33ENST0000035827333ENSE00001613913chr17:29585362-29585520159NF1_HUMAN1392-1444530--
1.34ENST0000035827334ENSE00001682969chr17:29586050-2958614798NF1_HUMAN1445-1477330--
1.35ENST0000035827335ENSE00001619767chr17:29587387-29587533147NF1_HUMAN1477-1526500--
1.36bENST0000035827336bENSE00001790168chr17:29588729-29588875147NF1_HUMAN1526-1575500--
1.37ENST0000035827337ENSE00001627455chr17:29592247-29592357111NF1_HUMAN1575-1612382A:1567-1591
B:1567-1591
25
25
1.38ENST0000035827338ENSE00001730796chr17:29652838-29653270433NF1_HUMAN1612-17561452A:1591-1735
B:1591-1735
145
145
1.39ENST0000035827339ENSE00001805635chr17:29654517-29654857341NF1_HUMAN1757-18701142A:1736-1816
B:1736-1816
81
81
1.40aENST0000035827340aENSE00001654020chr17:29657314-29657516203NF1_HUMAN1870-1938690--
1.42ENST0000035827342ENSE00001731551chr17:29661856-29662049194NF1_HUMAN1938-2002650--
1.43aENST0000035827343aENSE00001670698chr17:29663351-29663491141NF1_HUMAN2003-2049470--
1.44ENST0000035827344ENSE00001798398chr17:29663653-29663932280NF1_HUMAN2050-2143940--
1.45ENST0000035827345ENSE00001612636chr17:29664386-29664600215NF1_HUMAN2143-2214720--
1.46cENST0000035827346cENSE00001728730chr17:29664837-2966489862NF1_HUMAN2215-2235210--
1.47bENST0000035827347bENSE00000345386chr17:29665043-29665157115NF1_HUMAN2235-2273390--
1.48ENST0000035827348ENSE00000867931chr17:29665722-29665823102NF1_HUMAN2274-2307340--
1.49ENST0000035827349ENSE00001298195chr17:29667523-29667663141NF1_HUMAN2308-2354470--
1.50ENST0000035827350ENSE00000867933chr17:29670027-29670153127NF1_HUMAN2355-2397430--
1.51ENST0000035827351ENSE00000345390chr17:29676138-29676269132NF1_HUMAN2397-2441450--
1.52ENST0000035827352ENSE00000711432chr17:29677201-29677336136NF1_HUMAN2441-2486460--
1.55ENST0000035827355ENSE00000711463chr17:29679275-29679432158NF1_HUMAN2486-2539540--
1.56ENST0000035827356ENSE00000711466chr17:29683478-29683600123NF1_HUMAN2539-2580420--
1.57ENST0000035827357ENSE00000867938chr17:29683978-29684108131NF1_HUMAN2580-2623440--
1.58ENST0000035827358ENSE00000345395chr17:29684287-29684387101NF1_HUMAN2624-2657340--
1.59aENST0000035827359aENSE00000345396chr17:29685498-29685640143NF1_HUMAN2657-2705490--
1.60ENST0000035827360ENSE00000867941chr17:29685987-2968603347NF1_HUMAN2705-2720160--
1.61aENST0000035827361aENSE00000867942chr17:29687505-29687721217NF1_HUMAN2721-2793730--
1.63cENST0000035827363cENSE00001698901chr17:29701031-297046953665NF1_HUMAN2793-2839470--

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:250
 aligned with NF1_HUMAN | P21359 from UniProtKB/Swiss-Prot  Length:2839

    Alignment length:250
                                  1597      1607      1617      1627      1637      1647      1657      1667      1677      1687      1697      1707      1717      1727      1737      1747      1757      1767      1777      1787      1797      1807      1817      1827      1837
           NF1_HUMAN   1588 KTLSIFYQAGTSKAGNPIFYYVARRFKTGQINGDLLIYHVLLTLKPYYAKPYEIVVDLTHTGPSNRFKTDFLSKWFVVFPGFAYDNVSAVYIYNCNSWVREYTKYHERLLTGLKGSKRLVFIDCPGKLAEHIEHEQQKLPAATLALEEDLKVFHNALKLAHKDTKVSIKVGSTAVQVTSAERTKVLGQSVFLNDIYYASEIEEICLVDENQFTLTIANQGTPLTFMHQECEAIVQSIIHIRTRWELSQPD 1837
               SCOP domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....eeeeee.....eeeeee.........hhhhhhhhhhhhhhhhhh..eeeeee....hhhhh.hhhhhhhh....hhhhhhheeeeeee..hhhhhhhhhhh..hhhhhh....eeee.hhhhhhhhhhhhh...hhhhhhh...eeeeeeeeee....eeeeeeee..eeeeee...eee..eee..eeeee...eeeeeeee..eeeeee......eeee..hhhhhhhhhhhhhhhhhhh... Sec.struct. author
                 SAPs(SNPs) -----------------V-----W-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------S---------------------------------------------------- SAPs(SNPs)
                    PROSITE ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.37 [INCOMPLETE]   ------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.39  PDB: A:1736-1816 UniProt: 1757-1870 [INCOMPLETE]                       Transcript 1 (1)
           Transcript 1 (2) ------------------------Exon 1.38  PDB: A:1591-1735 UniProt: 1612-1756                                                                                                   --------------------------------------------------------------------------------- Transcript 1 (2)
                2e2x A 1567 KTLSIFYQAGTSKAGNPIFYYVARRFKTGQINGDLLIYHVLLTLKPYYAKPYEIVVDLTHTGPSNRFKTDFLSKWFVVFPGFAYDNVSAVYIYNCNSWVREYTKYHERLLTGLKGSKRLVFIDCPGKLAEHIEHEQQKLPAATLALEEDLKVFHNALKLAHKDTKVSIKVGSTAVQVTSAERTKVLGQSVFLNDIYYASEIEEICLVDENQFTLTIANQGTPLTFMHQECEAIVQSIIHIRTRWELSQPD 1816
                                  1576      1586      1596      1606      1616      1626      1636      1646      1656      1666      1676      1686      1696      1706      1716      1726      1736      1746      1756      1766      1776      1786      1796      1806      1816

Chain B from PDB  Type:PROTEIN  Length:250
 aligned with NF1_HUMAN | P21359 from UniProtKB/Swiss-Prot  Length:2839

    Alignment length:250
                                  1597      1607      1617      1627      1637      1647      1657      1667      1677      1687      1697      1707      1717      1727      1737      1747      1757      1767      1777      1787      1797      1807      1817      1827      1837
           NF1_HUMAN   1588 KTLSIFYQAGTSKAGNPIFYYVARRFKTGQINGDLLIYHVLLTLKPYYAKPYEIVVDLTHTGPSNRFKTDFLSKWFVVFPGFAYDNVSAVYIYNCNSWVREYTKYHERLLTGLKGSKRLVFIDCPGKLAEHIEHEQQKLPAATLALEEDLKVFHNALKLAHKDTKVSIKVGSTAVQVTSAERTKVLGQSVFLNDIYYASEIEEICLVDENQFTLTIANQGTPLTFMHQECEAIVQSIIHIRTRWELSQPD 1837
               SCOP domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author hhhh.eeeeee.....eeeeee.hhh..hhhhhhhhhhhhhhhhh......eeeeee....hhhhh.hhhhhhhhhh..hhhhhhheeeeeee..hhhhhhhhhhh.hhhhhh.....eeee...hhhhhh.hhhhh..hhhhhhh....eeeeeeeee....eeeeeeee..eeeeee...eee..eee..eeeee...eeeeeeee..eeeeee..eeeeeeee..hhhhhhhhhhhhhhhhhh.... Sec.struct. author
                 SAPs(SNPs) -----------------V-----W-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------S---------------------------------------------------- SAPs(SNPs)
                    PROSITE ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.37 [INCOMPLETE]   ------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.39  PDB: B:1736-1816 UniProt: 1757-1870 [INCOMPLETE]                       Transcript 1 (1)
           Transcript 1 (2) ------------------------Exon 1.38  PDB: B:1591-1735 UniProt: 1612-1756                                                                                                   --------------------------------------------------------------------------------- Transcript 1 (2)
                2e2x B 1567 KTLSIFYQAGTSKAGNPIFYYVARRFKTGQINGDLLIYHVLLTLKPYYAKPYEIVVDLTHTGPSNRFKTDFLSKWFVVFPGFAYDNVSAVYIYNCNSWVREYTKYHERLLTGLKGSKRLVFIDCPGKLAEHIEHEQQKLPAATLALEEDLKVFHNALKLAHKDTKVSIKVGSTAVQVTSAERTKVLGQSVFLNDIYYASEIEEICLVDENQFTLTIANQGTPLTFMHQECEAIVQSIIHIRTRWELSQPD 1816
                                  1576      1586      1596      1606      1616      1626      1636      1646      1656      1666      1676      1686      1696      1706      1716      1726      1736      1746      1756      1766      1776      1786      1796      1806      1816

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (0, 0)

(no "SCOP Domain" information available for 2E2X)

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 2E2X)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 2E2X)

(-) Gene Ontology  (88, 88)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A,B   (NF1_HUMAN | P21359)
molecular function
    GO:0005096    GTPase activator activity    Binds to and increases the activity of a GTPase, an enzyme that catalyzes the hydrolysis of GTP.
    GO:0008289    lipid binding    Interacting selectively and non-covalently with a lipid.
    GO:0031210    phosphatidylcholine binding    Interacting selectively and non-covalently with phosphatidylcholine, a class of glycophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of choline.
    GO:0008429    phosphatidylethanolamine binding    Interacting selectively and non-covalently with phosphatidylethanolamine, any of a class of glycerophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of ethanolamine.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
biological process
    GO:0000165    MAPK cascade    An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
    GO:0007265    Ras protein signal transduction    A series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state.
    GO:0014044    Schwann cell development    The process aimed at the progression of a Schwann cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. Schwann cells are found in the peripheral nervous system, where they insulate neurons and axons, and regulate the environment in which neurons function.
    GO:0030036    actin cytoskeleton organization    A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.
    GO:0030325    adrenal gland development    The process whose specific outcome is the progression of the adrenal gland over time, from its formation to the mature structure. This gland can either be a discrete structure located bilaterally above each kidney, or a cluster of cells in the head kidney that perform the functions of the adrenal gland. In either case, this organ consists of two cells types, aminergic chromaffin cells and steroidogenic cortical cells.
    GO:0021764    amygdala development    The progression of the amygdala over time from its initial formation until its mature state. The amygdala is an almond-shaped set of neurons in the medial temporal lobe of the brain that play a key role in processing emotions such as fear and pleasure.
    GO:0048844    artery morphogenesis    The process in which the anatomical structures of arterial blood vessels are generated and organized. Arteries are blood vessels that transport blood from the heart to the body and its organs.
    GO:0007420    brain development    The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
    GO:0048593    camera-type eye morphogenesis    The process in which the anatomical structures of the eye are generated and organized. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field.
    GO:0007154    cell communication    Any process that mediates interactions between a cell and its surroundings. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment.
    GO:0034605    cellular response to heat    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism.
    GO:0021987    cerebral cortex development    The progression of the cerebral cortex over time from its initial formation until its mature state. The cerebral cortex is the outer layered region of the telencephalon.
    GO:0050890    cognition    The operation of the mind by which an organism becomes aware of objects of thought or perception; it includes the mental activities associated with thinking, learning, and memory.
    GO:0030199    collagen fibril organization    Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
    GO:0030198    extracellular matrix organization    A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
    GO:0008625    extrinsic apoptotic signaling pathway via death domain receptors    A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with a ligand binding to a death domain receptor on the cell surface, and ends when the execution phase of apoptosis is triggered.
    GO:0021897    forebrain astrocyte development    The process aimed at the progression of an astrocyte that resides in the forebrain, from initial commitment of the cell to its fate, to the fully functional differentiated cell. An astrocyte is the most abundant type of glial cell. Astrocytes provide support for neurons and regulate the environment in which they function.
    GO:0048853    forebrain morphogenesis    The process in which the anatomical structures of the forebrain are generated and organized. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes especially the cerebral hemispheres, the thalamus, and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing, visceral functions, and voluntary motor functions).
    GO:0061534    gamma-aminobutyric acid secretion, neurotransmission    The regulated release of gamma-aminobutyric acid by a cell, in which the gamma-aminobutyric acid acts as a neurotransmitter.
    GO:0061535    glutamate secretion, neurotransmission    The controlled release of glutamate by a cell, in which the glutamate acts as a neurotransmitter.
    GO:0007507    heart development    The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
    GO:0001889    liver development    The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes.
    GO:0001656    metanephros development    The process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. In mammals, the metanephros is the excretory organ of the fetus, which develops into the mature kidney and is formed from the rear portion of the nephrogenic cord. The metanephros is an endocrine and metabolic organ that filters the blood and excretes the end products of body metabolism in the form of urine.
    GO:0022011    myelination in peripheral nervous system    The process in which neuronal axons and dendrites become coated with a segmented lipid-rich sheath (myelin) to enable faster and more energetically efficient conduction of electrical impulses. The sheath is formed by the cell membranes of Schwann cells in the peripheral nervous system. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier.
    GO:0043407    negative regulation of MAP kinase activity    Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
    GO:0043409    negative regulation of MAPK cascade    Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the MAPKKK cascade.
    GO:0035021    negative regulation of Rac protein signal transduction    Any process that stops, prevents, or reduces the frequency, rate or extent of Rac protein signal transduction.
    GO:0046580    negative regulation of Ras protein signal transduction    Any process that stops, prevents, or reduces the frequency, rate or extent of Ras protein signal transduction.
    GO:0016525    negative regulation of angiogenesis    Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
    GO:0048712    negative regulation of astrocyte differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of astrocyte differentiation.
    GO:0030336    negative regulation of cell migration    Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration.
    GO:0008285    negative regulation of cell proliferation    Any process that stops, prevents or reduces the rate or extent of cell proliferation.
    GO:0001953    negative regulation of cell-matrix adhesion    Any process that stops, prevents, or reduces the rate or extent of cell adhesion to the extracellular matrix.
    GO:0001937    negative regulation of endothelial cell proliferation    Any process that stops, prevents, or reduces the rate or extent of endothelial cell proliferation.
    GO:0048147    negative regulation of fibroblast proliferation    Any process that stops, prevents, or reduces the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
    GO:0007406    negative regulation of neuroblast proliferation    Any process that stops, prevents, or reduces the frequency, rate or extent of the proliferation of neuroblasts.
    GO:0046929    negative regulation of neurotransmitter secretion    Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of a neurotransmitter.
    GO:0048715    negative regulation of oligodendrocyte differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of oligodendrocyte differentiation.
    GO:0045671    negative regulation of osteoclast differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of osteoclast differentiation.
    GO:0006469    negative regulation of protein kinase activity    Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase activity.
    GO:0042992    negative regulation of transcription factor import into nucleus    Any process that stops, prevents, or reduces the frequency, rate or extent of the movement of a transcription factor from the cytoplasm to the nucleus.
    GO:0021915    neural tube development    The process whose specific outcome is the progression of the neural tube over time, from its formation to the mature structure. The mature structure of the neural tube exists when the tube has been segmented into the forebrain, midbrain, hindbrain and spinal cord regions. In addition neural crest has budded away from the epithelium.
    GO:0098597    observational learning    Learning that occurs through observing the behavior of others.
    GO:0001649    osteoblast differentiation    The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
    GO:0007422    peripheral nervous system development    The process whose specific outcome is the progression of the peripheral nervous system over time, from its formation to the mature structure. The peripheral nervous system is one of the two major divisions of the nervous system. Nerves in the PNS connect the central nervous system (CNS) with sensory organs, other organs, muscles, blood vessels and glands.
    GO:0014065    phosphatidylinositol 3-kinase signaling    A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions.
    GO:0043473    pigmentation    The accumulation of pigment in an organism, tissue or cell, either by increased deposition or by increased number of cells.
    GO:0043547    positive regulation of GTPase activity    Any process that activates or increases the activity of a GTPase.
    GO:0045762    positive regulation of adenylate cyclase activity    Any process that activates or increases the frequency, rate or extent of adenylate cyclase activity.
    GO:0043065    positive regulation of apoptotic process    Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
    GO:0001938    positive regulation of endothelial cell proliferation    Any process that activates or increases the rate or extent of endothelial cell proliferation.
    GO:2001241    positive regulation of extrinsic apoptotic signaling pathway in absence of ligand    Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
    GO:1902043    positive regulation of extrinsic apoptotic signaling pathway via death domain receptors    Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
    GO:0043525    positive regulation of neuron apoptotic process    Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
    GO:0043087    regulation of GTPase activity    Any process that modulates the rate of GTP hydrolysis by a GTPase.
    GO:0043408    regulation of MAPK cascade    Any process that modulates the frequency, rate or extent of signal transduction mediated by the MAP kinase (MAPK) cascade.
    GO:0045765    regulation of angiogenesis    Any process that modulates the frequency, rate or extent of angiogenesis.
    GO:0043535    regulation of blood vessel endothelial cell migration    Any process that modulates the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
    GO:0045124    regulation of bone resorption    Any process that modulates the frequency, rate or extent of bone tissue loss (resorption).
    GO:0042127    regulation of cell proliferation    Any process that modulates the frequency, rate or extent of cell proliferation.
    GO:0001952    regulation of cell-matrix adhesion    Any process that modulates the frequency, rate or extent of attachment of a cell to the extracellular matrix.
    GO:0010468    regulation of gene expression    Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
    GO:0045685    regulation of glial cell differentiation    Any process that modulates the frequency, rate or extent of glia cell differentiation.
    GO:0048169    regulation of long-term neuronal synaptic plasticity    A process that modulates long-term neuronal synaptic plasticity, the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers.
    GO:1900271    regulation of long-term synaptic potentiation    Any process that modulates the frequency, rate or extent of long-term synaptic potentiation.
    GO:0032228    regulation of synaptic transmission, GABAergic    Any process that modulates the frequency, rate or extent of GABAergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter gamma-aminobutyric acid (GABA).
    GO:0001666    response to hypoxia    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
    GO:0007165    signal transduction    The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
    GO:0007519    skeletal muscle tissue development    The developmental sequence of events leading to the formation of adult skeletal muscle tissue. The main events are: the fusion of myoblasts to form myotubes that increase in size by further fusion to them of myoblasts, the formation of myofibrils within their cytoplasm and the establishment of functional neuromuscular junctions with motor neurons. At this stage they can be regarded as mature muscle fibers.
    GO:0048745    smooth muscle tissue development    The process whose specific outcome is the progression of smooth muscle over time, from its formation to the mature structure.
    GO:0021510    spinal cord development    The process whose specific outcome is the progression of the spinal cord over time, from its formation to the mature structure. The spinal cord primarily conducts sensory and motor nerve impulses between the brain and the peripheral nervous tissues.
    GO:0048485    sympathetic nervous system development    The process whose specific outcome is the progression of the sympathetic nervous system over time, from its formation to the mature structure. The sympathetic nervous system is one of the two divisions of the vertebrate autonomic nervous system (the other being the parasympathetic nervous system). The sympathetic preganglionic neurons have their cell bodies in the thoracic and lumbar regions of the spinal cord and connect to the paravertebral chain of sympathetic ganglia. Innervate heart and blood vessels, sweat glands, viscera and the adrenal medulla. Most sympathetic neurons, but not all, use noradrenaline as a post-ganglionic neurotransmitter.
    GO:0008542    visual learning    Any process in an organism in which a change in behavior of an individual occurs in response to repeated exposure to a visual cue.
    GO:0042060    wound healing    The series of events that restore integrity to a damaged tissue, following an injury.
cellular component
    GO:0030424    axon    The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0005829    cytosol    The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
    GO:0030425    dendrite    A neuron projection that has a short, tapering, often branched, morphology, receives and integrates signals from other neurons or from sensory stimuli, and conducts a nerve impulse towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
    GO:0031235    intrinsic component of the cytoplasmic side of the plasma membrane    The component of a plasma membrane consisting of gene products and protein complexes that have some covalently attached part (e.g. peptide sequence or GPI anchor) which is embedded in the cytoplasmic side of the plasma membrane only.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005730    nucleolus    A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
    GO:0005634    nucleus    A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
    GO:0098793    presynapse    The part of a synapse that is part of the presynaptic cell.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    PEV  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    POP  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
(no "Sites" information available for 2e2x)
 
  Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 2e2x)
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2e2x
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  NF1_HUMAN | P21359
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  162200
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  NF1_HUMAN | P21359
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        NF1_HUMAN | P213591nf1 2d4q 3p7z 3peg 3pg7

(-) Related Entries Specified in the PDB File

2d4q CRYSTAL STRUCTURE OF THE SEC-PH SEGMENT OF NEUROFIBROMIN IN COMPLEX WITH DETERGENT